Core Insights - In October 2023, A-shares experienced a high-level fluctuation, with the Shanghai Composite Index slightly rising by 1.85%, while the Shenzhen Component and ChiNext Index fell by 1.1% and 1.56% respectively [2] - A total of 2,448 private equity products reached historical highs in net value, accounting for approximately 48.60% of private equity products established for over one year [2][3] - Among these products, 1,367 were non-quantitative, while 1,081 were quantitative [2] - The majority of products employed stock strategies, with 1,344 products (approximately 54.9%), followed by multi-asset strategies (397), futures and derivatives strategies (383), bond strategies (224), and combination fund products (100) [2] Product Types - Non-quantitative products accounted for 1,367, while quantitative products made up 1,081 [2] - Stock strategy products were the most prevalent, with 1,344 products, followed by multi-asset strategies (397), futures and derivatives strategies (383), bond strategies (224), and combination fund products (100) [2] Company Size - The largest number of products came from private equity firms with assets under 500 million, totaling 864 products (35% of the total) [3] - There were 430 products from firms with over 10 billion in assets [3] High-Performing Private Equity Firms - A total of 42 private equity firms had all their products reach historical highs in October, with 20 being subjective private equity firms, 14 quantitative, and 8 combining both strategies [4][5] - Among these, five firms with over 10 billion in assets included Ningbo Huanfang Quantitative, Century Frontier, Jiukun Investment, Qilin Investment, and Honghu Private Equity [5] Notable Products - The "Double Ten Fund" category, which includes products established for over 10 years with annualized returns exceeding 10%, had 18 products, with 13 being subjective long products [9] - Notable high-performing products included those from Beijing Xiyue Private Equity, which topped the subjective long product category, and Jiukun Investment, which had 18 products with significant returns [19][27] Strategy Performance - In the futures and derivatives strategy category, 197 products reached historical highs, with the top five products coming from Yizu Investment and Chiying Private Equity [20] - The multi-asset strategy category had 245 products, with the top performers being from Lu Yuan Private Equity and Hai Sheng Fund [24][27]

Core Insights - In September 2023, A-shares indices reached new highs, with the Shanghai Composite Index rising 0.64%, while the Shenzhen Component and ChiNext Index increased by 6.54% and 12.04% respectively [2] - A total of 2,993 private equity products achieved historical net value highs in September, representing approximately 62.22% of products established for over a year [2] - Among these products, 1,125 were quantitative, and 1,868 were non-quantitative, with stock strategy products being the most prevalent [2][3] Product Types - Stock strategy products accounted for 1,931, approximately 64.52% of the total, followed by multi-asset strategy products (443), futures and derivatives strategy products (339), bond strategy products (173), and combination fund products (107) [2] - The majority of products (1,252) came from private equity firms with assets under management below 500 million, while 429 products were from firms with over 10 billion [3] High-Performing Private Equity Firms - A total of 66 private equity firms had all their products reach historical highs in September, with 40 being subjective private equity firms, 19 quantitative, and 7 combining both strategies [4][5] - Among these, 8 firms with over 10 billion in assets included notable names such as Fusheng Asset and Ningbo Huanfang Quantitative [5] Notable Products - The "Double Ten Fund" category, which includes products established for over 10 years with annualized returns exceeding 10%, featured 30 products, predominantly subjective long products [13] - The top-performing products in the quantitative long category had a threshold return of over ***% [16] Investment Strategies - The quantitative long strategy had 476 products achieving historical highs, with the top five returns coming from firms like Huanrong Investment and Longyin Tiger Roar [16] - For subjective long strategies, 606 products reached new highs, with the top five returns from firms such as Shanghai Geru Private Equity and Beijing Xiyue Private Equity [19] Multi-Asset and Derivatives Strategies - Multi-asset strategy products numbered 268, with the top five returns coming from firms like Juku Investment and Yiku Capital [28] - In the futures and derivatives strategy category, 149 products reached historical highs, with a focus on quantitative and subjective CTA strategies [33]